Mutual Fund Details
NAV
₹14.7450
as on 15 Jul 2020, 10:55 PM
₹0.0170(0.12%)
Last Change
Schemes Managed By
Start SIP in this Mutual Fund
Min SIP Amount
₹1,000
Suggested Date
21st of Every Month
Investment Performance
would have given a return of
₹103,499
₹106,749
₹142,103
₹144,455
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹44,455
Profit (absolute return)
44.46%
in the last
1m
3m
1y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
13.07%
In the last 6 months
27.48%
In the last 1 year
44.46%
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
Mirae Asset Healthcare Fund Direct - Dividend Payout
as of 30 Jun 2020, 05:30 AM
₹640.00 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 year.
0.83%
Expense Ratio
Plan
Dividend
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 year.
Scheme Document
Sectors Holding in this Mutual Fund
as on 30 Jun 2020
Healthcare
86.21%
₹551.77 Cr
Chemicals
4.38%
₹28.05 Cr
Diversified
1.94%
₹12.42 Cr
Cash Holding
1.93%
₹12.38 Cr
Financial
0.88%
₹5.63 Cr
Companies Holding in this Mutual Fund
as on 30 Jun 2020
Sun Pharmaceutical Inds. Ltd.
10.98%
₹70.27 Cr
Dr. Reddy's Laboratories Ltd.
10.12%
₹64.77 Cr
Divi's Laboratories Ltd.
7.32%
₹46.85 Cr
Aurobindo Pharma Ltd.
6.38%
₹40.83 Cr
Ipca Laboratories Ltd.
6.37%
₹40.77 Cr
Cipla Ltd.
6.02%
₹38.53 Cr
Biocon Ltd.
5.56%
₹35.58 Cr
Lupin Ltd.
5.08%
₹32.51 Cr
Torrent Pharmaceuticals Ltd.
4.05%
₹25.92 Cr
Ajanta Pharma Ltd.
3.63%
₹23.23 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 30 Jun 2020
Sun Pharmaceutical Inds. Ltd.
10.98%
₹70.27 Cr
Dr. Reddy's Laboratories Ltd.
10.12%
₹64.77 Cr
Divi's Laboratories Ltd.
7.32%
₹46.85 Cr
Aurobindo Pharma Ltd.
6.38%
₹40.83 Cr
Ipca Laboratories Ltd.
6.37%
₹40.77 Cr
Cipla Ltd.
6.02%
₹38.53 Cr
Biocon Ltd.
5.56%
₹35.58 Cr
Lupin Ltd.
5.08%
₹32.51 Cr
Torrent Pharmaceuticals Ltd.
4.05%
₹25.92 Cr
Ajanta Pharma Ltd.
3.63%
₹23.23 Cr
View All
View All
This fund's returns:
44.46%Return Duration
1 Year
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹1000
Category Returns
24.91%
34.98%
1Y Returns
44.46
DSP Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
24.91%
34.98%
1Y Returns
43.01
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
24.91%
34.98%
1Y Returns
39.76
SBI Healthcare Opportunities Fund Direct Plan - Growth
EquityPharma
Min. Investment
₹500
Category Returns
24.91%
34.98%
1Y Returns
38.53
IDBI Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹500
Category Returns
24.91%
34.98%
1Y Returns
37.45
About Mirae Asset Healthcare Fund Direct - Dividend Payout
Mirae Asset Healthcare Fund Direct - Dividend Payout is a Equity mutual fund scheme from Mirae Asset Mutual Fund. This scheme was launched on 02 Jul 2018 and is currently managed by its fund manager Vrijesh Kasera. It has an AUM of ₹640.00 Crores and the latest NAV decalared is ₹14.745 as on 16 Jul 2020 at 6:28 pm.
Mirae Asset Healthcare Fund Direct - Dividend Payout scheme return performance in last 1 year is 44.46%, is 46.57% since scheme launch. The min. SIP amount to invest in this scheme is ₹1000.
Scheme Details
| AUM: | ₹640.00 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 02 Jul 2018 |
| Fund Type: | Open-End |
Scheme Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
AMC Information
Mirae Asset Mutual Fund
View AMC Details
₹45,269.99 Cr
AUM
47
Schemes
Address
Unit No.606 - 6th Floor,Windsor Building - Off. CST Road,Kalina, Santacruz (East),400098
Phone Number
Phone : 022-67800301 / 1800-2090-777
Email / Website
